Heron Therapeutics to Present at Upcoming Investor Conferences
Heron Therapeutics (Nasdaq: HRTX) announced its participation in upcoming investor conferences, focusing on enhancing patient care through innovative treatments. At the Jefferies London Healthcare Conference on November 18-19, 2021, a fireside chat will be available on-demand. Additionally, during the 4th Annual Evercore ISI HealthCONx Conference from November 30 - December 2, 2021, a live fireside chat is scheduled for December 1 at 2:40 PM ET. Webcasts of these events can be accessed via the Company's website.
- None.
- None.
SAN DIEGO, Nov. 11, 2021 /PRNewswire/ -- Heron Therapeutics, Inc. (Nasdaq: HRTX), a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs, today announced that Heron management will present and host one-on-one meetings at the following investor conferences.
Jefferies London Healthcare Conference: November 18-19, 2021
- Fireside chat will be available on-demand for attendees during the virtual portion of the meeting beginning on Thursday, November 18, 2021.
- A webcast of the fireside chat will be available on the Company's website at www.herontx.com in the Investor Resources section.
4th Annual Evercore ISI HealthCONx Conference: November 30 - December 2, 2021
- Fireside chat on Wednesday, December 1, 2021 at 2:40 pm ET.
- A live webcast of the fireside chat will be available on the Company's website at www.herontx.com in the Investor Resources section.
About Heron Therapeutics, Inc.
Heron Therapeutics, Inc. is a commercial-stage biotechnology company focused on improving the lives of patients by developing best-in-class treatments to address some of the most important unmet patient needs. Our advanced science, patented technologies, and innovative approach to drug discovery and development have allowed us to create and commercialize a portfolio of products that aim to advance the standard-of-care for acute care and oncology patients. For more information, visit www.herontx.com.
Forward-Looking Statements
This news release contains "forward-looking statements" as defined by the Private Securities Litigation Reform Act of 1995. Heron cautions readers that forward-looking statements are based on management's expectations and assumptions as of the date of this news release and are subject to certain risks and uncertainties that could cause actual results to differ materially. These risks and uncertainties include, but are not limited to, risks and uncertainties identified in the Company's filings with the Securities and Exchange Commission. Forward-looking statements reflect our analysis only on their stated date, and Heron takes no obligation to update or revise these statements except as may be required by law.
Investor Relations and Media Contact:
David Szekeres
Executive Vice President, Chief Operating Officer
Heron Therapeutics, Inc.
dszekeres@herontx.com
858-251-4447
View original content:https://www.prnewswire.com/news-releases/heron-therapeutics-to-present-at-upcoming-investor-conferences-301422611.html
SOURCE Heron Therapeutics, Inc.
FAQ
What is the date of Heron Therapeutics' presentation at the Jefferies London Healthcare Conference?
When will the fireside chat at the Evercore ISI HealthCONx Conference take place?
Where can I watch the webcasts of Heron Therapeutics' investor presentations?
What is the primary focus of Heron Therapeutics as mentioned in the press release?
What is the stock symbol for Heron Therapeutics?
